Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124-2 methylation

HPV and Gynecologic Cancer

Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial

Lancet Oncol.

Polman NJ, Ebisch RMF, Heideman DAM, Melchers WJG, Bekkers RLM, Molijn AC, Meijer CJLM, Quint WGV, Snijders PJF, Massuger LFAG, van Kemenade FJ, Berkhof J

doi: 10.1016/S1470-

HPV and Gynecologic Cancer

A proper triage for detecting women with high-risk human papillomavirus genotypes other than HPV16/18

Eur J Obstet Gynecol Reprod Biol.

Wang JJ, Lyu LP, Hu QW, Wan ZQ, Dong J, Pan M, Shen WW, Zhang S

doi: 10.1016/j.ejogrb.2017.10.021.

HPV and Gynecologic Cancer

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders

Br J Cancer.

Lam JUH, Elfström KM, Ejegod DM, Pedersen H, Rygaard C, Rebolj M, Lynge E, Juul KE, Kjær SK, Dillner J, Bonde J

doi: 10.1038/bjc.2017.371.

HPV and Gynecologic Cancer

Predictive value of HPV testing in self-collected and clinician-collected samples compared with cytology in detecting high-grade cervical lesions

Cancer Epidemiol Biomarkers Prev.

El-Zein M, Bouten S, Louvanto K, Gilbert L, Gotlieb WH, Hemmings R, Behr MA, Franco EL

doi: 10.1158/1055-9965.EPI-18-1338

HPV and Gynecologic Cancer

Human papillomavirus genotypes in anal high-grade squamous intraepithelial lesion (HSIL): anal intraepithelial neoplasia grades 2(AIN2) and 3(AIN3) are different

Cancer Epidemiol Biomarkers Prev.

Roberts JM, Poynten IM, Molano M, Machalek DA, Hillman RJ, Guzman P, Jin F, Templeton DJ, Fairley CK, Law C, Garland SM, Grulich AE, Cornall AM

doi: 10.1158/1055-9965.EPI-20-0664.

HPV and Gynecologic Cancer

Extended HPV genotyping to compare HPV type-distribution in self and provider-collected samples for cervical cancer screening

Cancer Epidemiol Biomarkers Prev.

Rohner E, Edelman C, Sanusi B, Schmitt JW, Baker A, Chesko K, Faherty B, Gregory SM, Romocki LS, Sivaraman V, Nelson JA, O'Connor S, Hudgens MG, Knittel AK, Rahangdale L, Smith JS

doi: 10.1158/1055-9965.EPI-20-0674.

HPV and Gynecologic Cancer

Evaluation of guidelines for observational management of cervical intraepithelial neoplasia 2 in young women

Am J Obstet Gynecol.

Dempster-Rivett K, Innes CR, Simcock BJ, Harker D, Williman JA, Van Der Griend RA, Whitehead M, Hibma M, Lawton BA, Fitzgerald P, Dudley NM, Petrich S, Faherty J, Bergzoll C, Eva L, Sadler L, Pather S, Wrede CD, Sykes PH

doi: 10.1016/j.ajog.2020.02.029.

HPV and Gynecologic Cancer

Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study

Eur J Cancer.

Loopik DL, IntHout J, Melchers WJG, Massuger LFAG, Bekkers RLM, Siebers AG

doi: 10.1016/j.ejca.2019.10.009.

HPV and Gynecologic Cancer

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial

JAMA.

Ogilvie GS, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan D, Lee M, Martin RE, Gentile L, Peacock S, Stuart GCE, Franco EL, Coldman AJ

doi: 10.1001/jama.2018.7464.

Related content

Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial

A proper triage for detecting women with high-risk human papillomavirus genotypes other than HPV16/18

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders

Predictive value of HPV testing in self-collected and clinician-collected samples compared with cytology in detecting high-grade cervical lesions

Human papillomavirus genotypes in anal high-grade squamous intraepithelial lesion (HSIL): anal intraepithelial neoplasia grades 2(AIN2) and 3(AIN3) are different

Extended HPV genotyping to compare HPV type-distribution in self and provider-collected samples for cervical cancer screening

Evaluation of guidelines for observational management of cervical intraepithelial neoplasia 2 in young women

Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial